Mr. Kevin Bottomley reports

TRUE LEAF GRANTS NEW BATCH OF INCENTIVE STOCK OPTIONS

True Leaf Medicine International Ltd. has granted options to purchase an aggregate of 2,799,995 common shares to certain of its directors, officers, employees and consultants at an exercise price of 18.5 cents per share for a maximum term of five years.

Of this group, five insiders of the company received a total of 1,642,855 options. All of the options vest immediately.

As a result of this grant, the company now has a total of 5,879,995 options outstanding, representing 10.2 per cent of its issued and outstanding common shares.

About True Leaf Medicine

True Leaf Medicine, through its wholly owned subsidiary, True Leaf Pet Inc., has entered the $104.9-billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe. The company has also filed an application under Health Canada's access to cannabis for medical purposes regulations (ACMPR) to become a Canadian-licensed producer through its True Leaf Medicine Inc. subsidiary.

We seek Safe Harbor.